- Home
- HSDT
HSDT
Helius Medical Technologies Inc. (DE)
as 03-31-2025 12:38pm EST
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | NEWTOWN |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 134.7K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.33 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.37 - $7.19 | Next Earning Date: | 05-12-2025 |
| Revenue: | $520,000 | Revenue Growth: | -19.25% |
| Revenue Growth (this year): | -25.88% | Revenue Growth (next year): | 8.97% |
Latest Helius Medical Technologies Inc. (DE) News
HSDT Breaking Stock News: Dive into HSDT Ticker-Specific Updates for Smart Investing
Medical Device Network
17 days ago
Helius joins BCI landscape with new subsidiary
GlobeNewswire
18 days ago
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary
GlobeNewswire
20 days ago
Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
GlobeNewswire
2 months ago
Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study
GlobeNewswire
2 months ago
Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market
MT Newswires
2 months ago
Top Premarket Gainers
GlobeNewswire
2 months ago
Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target
MT Newswires
3 months ago
Sector Update: Health Care
Compare HSDT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HSDT Helius Medical Technologies Inc. (DE) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.